Purchase Order 36C26221P1687
Award Date 8/26/21
Potential Completion Date 8/25/26
Potential Value $442K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
VETERANS ADMINISTRATION, CA 90073, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 (VA - VHA VISN 16) awarded a $247,199.70 firm fixed price purchase order to Biocartis US Inc. for IDYLLA services. The contract has a one-year period of performance from July 1, 2023 through June 30, 2024. Biocartis US Inc. will deliver its IDYLLA molecular diagnostic testing platform and services from its location in Jersey City, New Jersey to support the VA - VHA VISN 16's healthcare...
- The U.S. Department of Veterans Affairs (VA) awarded a $14,220.00 firm fixed price purchase order to Biocartis US Inc., a foreign-owned for-profit organization, for FY25 Biocartis service agreement. The contract supports the provision of medical and laboratory equipment and supplies, primarily related to cancer research and diagnostics, including the Idylla instrument and related assays and reagents. The contract has no set-aside designation and will be performed in Asheville, North Carolina,...
- This is a $92,917.50 firm-fixed price purchase order awarded by the Department of Veterans Affairs (VA) to Biocartis US Inc., a large foreign-owned for-profit business, for Biocartis Idylla reagents and supplies. The contract supports the Asheville VA Medical Center's Pathology and Lab department in performing molecular testing of tumors and malignancies using the Biocartis Idylla system. The Idylla system allows the VA's pharmacists and oncologists to determine the best course of treatment...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 7, awarded a firm fixed-price purchase order valued at $116,829.71 to Biocartis US Inc. for cancer marker testing services utilizing the company's Idylla molecular diagnostic platform. The contract, posted as a special notice on March 1, 2022, and awarded on May 16, 2022, requires performance through May 15, 2027, at the contractor's facility in Jersey City, New Jersey. This award was issued through full and open...
- The U.S. Department of Veterans Affairs (VA), Veterans Integrated Service Network 10 (VISN 10) awarded a $54,035.53 firm-fixed price purchase order contract to Biocartis US Inc., a foreign-owned for-profit organization, for a Biocartis Idylla Service Agreement at the Louis Stokes Cleveland VA Medical Center. This sole-source contract is for the provision of the Idylla molecular diagnostic testing platform, including instruments, assays, and reagents, to support cancer research and diagnostics at...
- The U.S. Department of Veterans Affairs, through Veterans Integrated Service Network 6, awarded a $42,660 firm-fixed-price purchase order to Biocartis US Inc. for the provision of a Biocartis Idylla service agreement at the Charles George VA Medical Center in Asheville, North Carolina. The contract, awarded on December 9, 2025, with an ultimate completion date of December 8, 2028, was awarded through full and open competition with no set-aside designation. Biocartis US Inc., a foreign-owned...
- This firm fixed price purchase order was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 6 to Veterans Healthcare Supply Solutions Inc. for the delivery of BioCartis Idylla reagent assays. The solicitation requested quotes for six assay types totaling 142 packs from BioCartis US Inc. to be delivered to the Asheville VA Medical Center. Valued at $105,100, the contract has a period of performance of October 1, 2022 through...
- This is a $87,846 firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Veterans Healthcare Supply Solutions, Inc., a Service-Disabled Veteran-Owned Small Business (SDVOSB), for the delivery of BioCartis Idylla Console and Instrument medical devices. The contract has an ultimate completion date of August 31, 2019. The original solicitation was a combined synopsis/solicitation for commercial items under NAICS code 339113. This purchase order...
- This is a firm-fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) to Biocartis US Inc., a foreign-owned, for-profit organization. The contract is for the procurement of MSI (microsatellite instability) testing reagent cartridges for the VA Greater Los Angeles Healthcare System's Pathology and Laboratory Medicine Services Department. The contract has a ceiling value of $62,361.00 and a performance period of January 31, 2027. This contract was awarded through...
- The Department of Veterans Affairs (VA) awarded a firm-fixed price purchase order contract to Biocartis US Inc. for the procurement of MSI (Microsatellite Instability) testing reagents for the Greater Los Angeles VA Healthcare System. The contract, valued at $60,479.12, has a period of performance of 1 year and the products must be compatible with the Biocartis Idyla System. There was no set-aside designation for this full and open competition solicitation, which was issued as a Request for...
The U.S. Department of Veterans Affairs (VA) awarded a $441,828.09 firm-fixed-price purchase order contract to Biocartis US Inc. for the provision of Idylla instruments, EGFR assays, and related supplies and reagents. The contract is for the Veterans Integrated Service Network 22 (VISN 22) and has an ultimate completion date of August 25, 2026. The contract does not have a set-aside designation. Biocartis US Inc. is the prime contractor, and the contract does not indicate any major subcontractors. The VA is the funding agency, and the contract supports the agency's healthcare operations and cancer research and diagnostics initiatives.
Generated 8/15/24, 9:45 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Supplemental Agreement for work within scope | $0 | 8/17/22 | |
| P00002 | Exercise an Option | $103.9k | 8/17/22 | |
| Not listed | Not listed | $67.6k | 8/26/21 |